Formic Acid

Formic Acid

SCHEMBL9933150

Cn1c(-c2nc(N3CCNCC3)ccc2Cl)nc2ccccc21.O=CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
CYP3A4 P08684 2/20 0.44
HSD17B10 Q99714 2/20 0.44
HTR3A P46098 5/20 0.43
HTR3E A5X5Y0 3/20 0.43
HTR3B O95264 3/20 0.43
HTR3D Q70Z44 3/20 0.43
HTR3C Q8WXA8 3/20 0.43
ADRB1 P08588 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HTR2C P28335 2/20 0.43
USP2 O75604 1/20 0.43
CYP1A2 P05177 1/20 0.43
HTR1A P08908 1/20 0.43
MAPK1 P28482 1/20 0.43
SLC6A4 P31645 1/20 0.43
HTR7 P34969 1/20 0.43
HTT P42858 1/20 0.43
HTR6 P50406 1/20 0.43
PMP22 Q01453 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9968519 0.94 HTR3A (0.49) KDM4ECYP3A4HSD17B10HTR3AHTR3E
SCHEMBL9932793 0.85 KDM4E (0.42) KDM4ECYP3A4HSD17B10HTR3AHTR3E
SCHEMBL9968420 0.82 HTR3A (0.51) KDM4EHTR3AHTR3EHTR3BHTR3D
SCHEMBL9931839 0.81 MEN1 (0.46) KDM4EALDH1A1NCF1POLBGAA
SCHEMBL9968415 0.81 MEN1 (0.41) KDM4ECYP3A4HSD17B10HTR3AHTR3E
SCHEMBL9932543 0.81 SMO (0.45) KDM4ECYP3A4HSD17B10ALDH1A1MAPK1
SCHEMBL9968416 0.79 TSHR (0.43) KDM4ECYP3A4HSD17B10ALDH1A1MAPK1
SCHEMBL9968419 0.79 MEN1 (0.41) KDM4ECYP3A4HSD17B10HTR3AHTR3E
SCHEMBL9932626 0.79 HSD11B1 (0.48) ALDH1A1GAASMN1; SMN2
SCHEMBL9932064 0.78 ALDH1A1 (0.46) ALDH1A1HTTPOLBGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157471-A1 BENZIMIDAZOLE DERIVATIVES PFIZER INC. (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157471-A1 BENZIMIDAZOLE DERIVATIVES SMO, RB1, GLI1 KDM4E 258/4885CYP3A4 3563/4885HSD17B10 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.